Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

TARO-ATENOLOL 50 MG — DIN 02267985

ATENOLOL : 50 MG · SUN PHARMA CANADA INC · TABLET · wholesale supply in Canada

Health Canada status: MARKETED

What is TARO-ATENOLOL?

TARO-ATENOLOL 50 MG contains ATENOLOL : 50 MG. It is listed in the Health Canada Drug Product Database under DIN 02267985, held by SUN PHARMA CANADA INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 23-Jan-2020. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

How much does Atenolol cost around the world?

Atenolol is listed on 16 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.

What a market publishes matters more than the number it publishes. Australia publishes a ex-manufacturer; Bahrain publishes a retail (max); Belgium publishes a public. Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.

MarketPrice basis published thereBrandsPacks listedRange
Brazilpreco fabrica (ex-factory ceiling)767BRL███.██
United Statesacquisition353USD███.██
Saudi Arabiapublic3441SAR███.██
South Africasingle exit price2931ZAR███.██
SpainPVP con IVA (public price)2727EUR███.██
MoroccoPPV (public price)820MAD███.██
Australiaex-manufacturer918AUD███.██
Bahrainretail (max)616BHD███.██
United Arab Emiratespublic1015AED███.██
SwedenAIP (pharmacy purchase price)515SEK███.██
Norwaymax AUP (pharmacy retail)211NOK███.██
Romaniamax producer price68RON███.██
Belgiumpublic66EUR███.██
United Kingdomhospital44GBP███.██
Greeceproducer price (ex-factory)44EUR███.██
Slovakiacategorised final price22EUR███.██

338 pack listings across 162 brand entries and 14 price bases, refreshed 08 Sep 2026. Ranges span every Atenolol pack in that market, so a high figure is usually a larger pack rather than the same product.

Figures are held for the Nexara team. Cross-market prices are published on incompatible bases and are not an offer, a landed cost, or a guide to what any buyer can obtain. Nexara publishes which markets list the product and on what basis; the numbers stay internal.

Team sign-in

Canada publishes no comparable public list price. For a delivered Canadian price on a licensed account, verify your licence — it takes about a minute.

Ask Nexara for a landed Canadian price

Is there a generic Atenolol in Canada, and who makes it?

Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.

32 holders have a Canadian DIN containing Atenolol, across 87 DINs, of which 28 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.

Market authorization holderDINsMarketedBrand namesPosition
TEVA CANADA LIMITED83NTP-ATENOL, TEVA-ATENOLOLSourceable in Canada
MARCAN PHARMACEUTICALS INC63IPG-ATENOLOL, MAR-ATENOLOLSourceable in Canada
JAMP PHARMA CORPORATION43JAMP ATENOLOL TABLETS, JAMP-ATENOLOLSourceable in Canada
SIVEM PHARMACEUTICALS ULC43ATENOLOLSourceable in Canada
MINT PHARMACEUTICALS INC33MINT-ATENOLSourceable in Canada
PHARMASCIENCE INC33PMS-ATENOLOLSourceable in Canada
PRO DOC LIMITEE33ATENOLOLSourceable in Canada
SUN PHARMA CANADA INC33TARO-ATENOLOLSourceable in Canada
APOTEX INC22APO-ATENOL TAB 100MG, APO-ATENOL TAB 50MGSourceable in Canada
SEARCHLIGHT PHARMA INC22TENORMINSourceable in Canada
BIOMED PHARMA30BIO-ATENOLOLNo marketed DIN
LABORATOIRE RIVA INC.30RIVA-ATENOLOLNo marketed DIN

Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.

How is it supplied and stored?

Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.

Strength on the label50 MG
Dosage formTABLET
RouteORAL

Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.

Substance and classification

Active substanceAtenolol
ATC codeC07AB03
Biosimilar biologicNo

Confirm the pack and get a price

Health Canada record and identifiers

The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.

DIN (8-digit, as used in ordering)02267985
DIN (unpadded, as printed on some documents)2267985
Brand nameTARO-ATENOLOL
Generic / active ingredientATENOLOL : 50 MG
Market authorization holderSUN PHARMA CANADA INC
Health Canada schedulePrescription
ATC codeC07AB03
ATC anatomical main groupC — Cardiovascular system
ATC therapeutic subgroupC07AB
Current statusMARKETED
Status date23-Jan-2020
Status sourceLive Health Canada DPD sync

Verify on the primary sources

Health Canada DPD record Approved product monograph (PDF)

Is Atenolol in shortage in Canada?

A Canadian shortage report is on file for a product containing this molecule: Anticipated — reported by SANIS HEALTH INC, last seen 09 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.

Check availability for TARO-ATENOLOL

What can be used instead?

Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.

1 · Same molecule, other Canadian presentations

28 of 87 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.

ProductStrengthFormHolderHealth Canada statusDIN
APO-ATENOL TAB 100MG100 MGTABLETAPOTEX INCMARKETED00773697
APO-ATENOL TAB 50MG50 MGTABLETAPOTEX INCMARKETED00773689
ATENOLOL50 MGTABLETPRO DOC LIMITEEMARKETED00828807
ATENOLOL100 MGTABLETSIVEM PHARMACEUTICALS ULCMARKETED02238318
ATENOLOL25 MGTABLETPRO DOC LIMITEEMARKETED02326701
ATENOLOL50 MGTABLETSIVEM PHARMACEUTICALS ULCMARKETED02238316
ATENOLOL25 MGTABLETSIVEM PHARMACEUTICALS ULCMARKETED02541564
ATENOLOL100 MGTABLETPRO DOC LIMITEEMARKETED00828793
JAMP-ATENOLOL50 MGTABLETJAMP PHARMA CORPORATIONMARKETED02367564
JAMP-ATENOLOL25 MGTABLETJAMP PHARMA CORPORATIONMARKETED02367556

2 · Same class — other molecules in ATC C07AB

MoleculeCanadian brandsDINsMarketedSourceable
MetoprololAA-METOPROLOL SR · AG-METOPROLOL-L · APO-METOPROLOL · APO-METOPROLOL (TYPE L) · +44 more10330Yes
AtenololACT ATENOLOL · AG-ATENOLOL · APO-ATENOL TAB 100MG · APO-ATENOL TAB 50MG · +35 more8728Yes
BisoprololAG-BISOPROLOL · APO-BISOPROLOL · AVA-BISOPROLOL · BISOPROLOL · +19 more5224Yes
NebivololAPO-NEBIVOLOL · BYSTOLIC · JAMP NEBIVOLOL · PRZ-NEBIVOLOL139Yes
AcebutololACEBUTOLOL · ACEBUTOLOL - 400 · ACEBUTOLOL-100 · ACEBUTOLOL-200 · +20 more446Yes
EsmololBREVIBLOC INJECTION 10MG/ML · BREVIBLOC INJECTION 250MG/ML · BREVIBLOC LIQ IV 10MG/ML · BREVIBLOC LIQ IV 250MG/ML · +1 more52Yes
LandiololSIBBORAN10Not in Canada

A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.

3 · Adjacent classes in ATC C07A

ATC subgroupMoleculesDINsMarketed
C07AGCarvedilol · Labetalol9938
C07AANadolol · Oxprenolol · Pindolol · Propranolol · Sotalol · +1 more17727

Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.

What else is TARO-ATENOLOL called?

The same molecule, Atenolol, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:

NameScriptRegistered in
ATENOLOLLatinBrazil
Atenolol ViatrisLatinNorway, Sweden
ATENOLABLatinBrazil
BetatenLatinBahrain, Saudi Arabia
Atenolol Medical ValleyLatinNorway, Sweden
TenorminLatinAustralia, Bahrain
ZOTROLLatinMorocco
ANGIPRESSLatinBrazil
ABLOKLatinBrazil
Atenolol AccordLatinSweden
Atenolol OrifarmLatinSweden
Atenolol TevaLatinSweden
ATENORLatinMorocco
TENORMINELatinMorocco
XYTENOLLatinMorocco

Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.

How can I get it?

Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.

Request a quote for TARO-ATENOLOL

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Why is there no price on this page?

Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Sources and disclaimer

Product data sourced from the Health Canada Drug Product Database and the approved product monograph (PDF). Health Canada status reconciled against the live DPD sync. Last reviewed 10 Sep 2026.

Nothing on this page is medical advice. Nexara Health is a licensed wholesale distributor and supplies licensed entities only; consumer orders are routed to a partner pharmacy. Alternatives tables describe supply, not clinical equivalence.

Health Canada Drug Product Database (DPD), DIN 02267985. Last reviewed 2026-09-10. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.